Evidence map›Paper›PMID 36013186›Full record

ArticleJournal of personalized medicine2022

Mental Health Symptom Reduction Using Digital Therapeutics Care Informed by Genomic SNPs and Gut Microbiome Signatures.

Inti Pedroso, Shreyas Vivek Kumbhare, Bharat Joshi, Santosh K Saravanan, Dattatray Suresh Mongad, Simitha Singh-Rambiritch, Tejaswini Uday, Karthik Marimuthu Muthukumar, Carmel Irudayanathan, Chandana Reddy-Sinha and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Digital therapeutics in the clinic.Bioengineering & translational medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Inti PedrosoDigbi Health, Mountain View, CA 94040, USA.ORCID 0000-0002-5947-4556
Shreyas Vivek KumbhareDigbi Health, Mountain View, CA 94040, USA.
Bharat JoshiDigbi Health, Mountain View, CA 94040, USA.
Santosh K SaravananDigbi Health, Mountain View, CA 94040, USA.
Dattatray Suresh MongadNational Centre for Cell Science, Pune 411007, India.
Simitha Singh-RambiritchDigbi Health, Mountain View, CA 94040, USA.
Tejaswini UdayDigbi Health, Mountain View, CA 94040, USA.
Karthik Marimuthu MuthukumarDigbi Health, Mountain View, CA 94040, USA.
Carmel IrudayanathanDigbi Health, Mountain View, CA 94040, USA.
Chandana Reddy-SinhaDigbi Health, Mountain View, CA 94040, USA.
Parambir S DulaiDivision of Gastroenterology, Northwestern University, Chicago, IL 60208, USA.
Ranjan SinhaDigbi Health, Mountain View, CA 94040, USA.ORCID 0000-0003-2485-8549
Daniel Eduardo AlmonacidDigbi Health, Mountain View, CA 94040, USA.ORCID 0000-0002-1788-2084
National Centre for Cell Science · INNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropsychiatric diseases and obesity are major components of morbidity and health care costs, with genetic, lifestyle, and gut microbiome factors linked to their etiology. Dietary and weight-loss interventions can help improve mental health, but there is conflicting evidence regarding their efficacy; and moreover, there is substantial interindividual heterogeneity that needs to be understood. We aimed to identify genetic and gut microbiome factors that explain interindividual differences in mental health improvement after a dietary and lifestyle intervention for weight loss. We recruited 369 individuals participating in Digbi Health’s personalized digital therapeutics care program and evaluated the association of 23 genetic scores, the abundance of 178 gut microbial genera, and 42 bacterial pathways with mental health. We studied the presence/absence of anxiety or depression, or sleep problems at baseline and improvement on anxiety, depression, and insomnia after losing at least 2% body weight. Participants lost on average 5.4% body weight and >95% reported improving mental health symptom intensity. There were statistically significant correlations between: (a) genetic scores with anxiety or depression at baseline, gut microbial functions with sleep problems at baseline, and (b) genetic scores and gut microbial taxa and functions with anxiety, depression, and insomnia improvement. Our results are concordant with previous findings, including the association between anxiety or depression at baseline with genetic scores for alcohol use disorder and major depressive disorder. As well, our results uncovered new associations in line with previous epidemiological literature. As evident from previous literature, we also observed associations of gut microbial signatures with mental health including short-chain fatty acids and bacterial neurotoxic metabolites specifically with depression. Our results also show that microbiome and genetic factors explain self-reported mental health status and improvement better than demographic variables independently. The genetic and microbiome factors identified in this study provide the basis for designing and personalizing dietary interventions to improve mental health.

Indexed as

anxietydepressiongut-brain-axisinsomniamulti-omic modelsnon-pharmacological treatment

Identifiers

PMID36013186
PMCPMC9409755
OpenAlexW4288434482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.